These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

231 related items for PubMed ID: 12683698

  • 1. Pharmacological management of type 2 diabetes mellitus: rationale for rational use of insulin.
    Chan JL, Abrahamson MJ.
    Mayo Clin Proc; 2003 Apr; 78(4):459-67. PubMed ID: 12683698
    [Abstract] [Full Text] [Related]

  • 2. Type II diabetes mellitus.
    Edelman SV.
    Adv Intern Med; 1998 Apr; 43():449-500. PubMed ID: 9506190
    [Abstract] [Full Text] [Related]

  • 3. Oral antidiabetic agents: current role in type 2 diabetes mellitus.
    Krentz AJ, Bailey CJ.
    Drugs; 2005 Apr; 65(3):385-411. PubMed ID: 15669880
    [Abstract] [Full Text] [Related]

  • 4. Advancing therapy in type 2 diabetes mellitus with early, comprehensive progression from oral agents to insulin therapy.
    Vinik A.
    Clin Ther; 2007 Apr; 29 Spec No():1236-53. PubMed ID: 18046925
    [Abstract] [Full Text] [Related]

  • 5. Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus.
    Plosker GL, Figgitt DP.
    Pharmacoeconomics; 2004 Apr; 22(6):389-411. PubMed ID: 15099124
    [Abstract] [Full Text] [Related]

  • 6. New strategies for basal insulin treatment in type 2 diabetes mellitus.
    Dailey G.
    Clin Ther; 2004 Jun; 26(6):889-901. PubMed ID: 15262459
    [Abstract] [Full Text] [Related]

  • 7. Management of type 2 diabetes mellitus in the elderly: special considerations.
    Rosenstock J.
    Drugs Aging; 2001 Jun; 18(1):31-44. PubMed ID: 11232737
    [Abstract] [Full Text] [Related]

  • 8. Therapy for type 2 diabetes mellitus.
    Elson DF, Meredith M.
    WMJ; 1998 Mar; 97(3):49-54. PubMed ID: 9540451
    [Abstract] [Full Text] [Related]

  • 9. Clinical importance of insulin secretion and its interaction with insulin resistance in the treatment of type 2 diabetes mellitus and its complications.
    Porte D.
    Diabetes Metab Res Rev; 2001 Mar; 17(3):181-8. PubMed ID: 11424231
    [Abstract] [Full Text] [Related]

  • 10. Gycemic control, mealtime glucose excursions, and diabetic complications in type 2 diabetes mellitus.
    Palumbo PJ.
    Mayo Clin Proc; 2001 Jun; 76(6):609-18. PubMed ID: 11393500
    [Abstract] [Full Text] [Related]

  • 11. [Hypoglycemic therapy in heart disease patients with type 2 diabetes mellitus].
    Cosmi F, Cosmi D.
    G Ital Cardiol (Rome); 2010 Jun; 11(6):460-6. PubMed ID: 20922871
    [Abstract] [Full Text] [Related]

  • 12. Managing type 2 diabetes: going beyond glycemic control.
    Stolar MW, Hoogwerf BJ, Gorshow SM, Boyle PJ, Wales DO.
    J Manag Care Pharm; 2008 Jun; 14(5 Suppl B):s2-19. PubMed ID: 18597582
    [Abstract] [Full Text] [Related]

  • 13. Long-term benefits of insulin therapy and glycemic control in overweight and obese adults with type 2 diabetes.
    Caballero AE.
    J Diabetes Complications; 2009 Jun; 23(2):143-52. PubMed ID: 18413192
    [Abstract] [Full Text] [Related]

  • 14. New concepts in diabetes: how multihormonal regulation can improve glycemic control.
    Blonde L, Baker DE, Davis SN, Ratner RE.
    J Manag Care Pharm; 2004 Dec; 10(6 Suppl B):S3-8; quiz S9, S11-2. PubMed ID: 23570175
    [Abstract] [Full Text] [Related]

  • 15. Issues surrounding tight glycemic control in people with type 2 diabetes mellitus.
    Cerveny JD, Leder RD, Weart CW.
    Ann Pharmacother; 1998 Sep; 32(9):896-905. PubMed ID: 9762378
    [Abstract] [Full Text] [Related]

  • 16. Treatment of diabetes: a clinical update on insulin trials.
    LeRoith D.
    Clin Cornerstone; 2007 Sep; 8(2):21-9; discussion 30-2. PubMed ID: 18357953
    [Abstract] [Full Text] [Related]

  • 17. Insulin therapy for maximal glycemic control in type 2 diabetes mellitus.
    Spellman CW.
    J Am Osteopath Assoc; 2007 Jul; 107(7):260-9. PubMed ID: 17682113
    [Abstract] [Full Text] [Related]

  • 18. Combination therapy with insulin and oral agents: optimizing glycemic control in patients with type 2 diabetes mellitus.
    Yki-Järvinen H.
    Diabetes Metab Res Rev; 2002 Jul; 18 Suppl 3():S77-81. PubMed ID: 12324990
    [Abstract] [Full Text] [Related]

  • 19. Glucose control and insulin resistance in non-insulin-dependent diabetes mellitus.
    Henry RR.
    Ann Intern Med; 1996 Jan 01; 124(1 Pt 2):97-103. PubMed ID: 8554221
    [Abstract] [Full Text] [Related]

  • 20. Management of type 2 diabetes: oral agents, insulin, and injectables.
    Fonseca VA, Kulkarni KD.
    J Am Diet Assoc; 2008 Apr 01; 108(4 Suppl 1):S29-33. PubMed ID: 18358251
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.